José Morales
Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.
Assistant Professor
Also affiliated: Universidad San Pablo CEU (2013); Universidad de Las Palmas de Gran Canaria (1991); Universidad Complutense de Madrid (1990–2017); Texas Tech University (1992–2006); Cedars-Sinai Medical Center (1969); Boston Children's Hospital (2014); Harvard University (2014); Johns Hopkins University (2015); University of California, Los Angeles (2021–2023); Pontificia Universidad Católica de Chile (2023–2024); Textron Systems (United Kingdom) (2018); Trinity College (2018); UCLA Health (2022–2024); Renal Association (2006); Ronald Reagan UCLA Medical Center (2023); University of California System (2021); Hospital Clínico San Carlos (2009); Research Institute Hospital 12 de Octubre (1987–2020); Ruhrlandklinik (1981); Los Angeles Medical Center (2026); Pediatric Nephrology of Alabama (2008); Asociación para la Conservación de la Cuenca Amazónica (2018); King Khaled Eye Specialist Hospital (2007–2017); Hospital Universitario 12 De Octubre (1999–2020); Instituto de Historia (2018); Ciência Viva (2017); Associação de Assistência à Criança Deficiente (2018); Neuroscience Institute (2023); Direction de la Recherche Fondamentale (2018); Universidad de los Hemisferios (2017); Mayo Clinic in Arizona (2022); De Gruyter Brill (Germany) (2017); Pacific Heart Institute (2023); Clinica Universidad de Navarra (1970); Instituto de Investigaciones Eléctricas (1991); Centro Nacional de Investigación y Desarrollo Tecnológico (2001–2013); Transports Metropolitans de Barcelona (Spain) (2021); Universidad Técnica de Ambato (2015); Instituto Nacional de las Mujeres (2017); Hospital Universitario Virgen del Rocío (1996); Hepatitis B Foundation (1999); Neurological Surgery (2024); Center for Rheumatology (2024); Hospital de León (2005–2018); Glaucoma Research Foundation (2006); Ophthalmology Associates (United States) (2012); Complejo Asistencial Universitario de Palencia (2013); Pharmacoeconomics and Health Outcomes Research Iberia (Spain) (2007); Imperial College London (2010); University of Córdoba (1991); Universidad de León (2008–2016); University of Hong Kong (2018); Texas Tech University Health Sciences Center (1998–2006)
Faculty Researcher
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
José Morales is an Assistant Professor and Neurointerventional Surgeon at the University of Arkansas for Medical Sciences. His research interests span various areas, including the development of miniaturized transducers for localized cavitation, the study of aging-associated immune deficiencies, and the investigation of intracranial atherosclerotic disease. He has also explored robotic diagnostic cerebral angiography and microfabrication approaches for dental research and simulating dental aging.
Morales's academic background includes training in neurology, vascular neurology, and interventional neuroradiology from Northwestern University and the University of California Los Angeles. His earlier research at Harvard Medical School focused on the neuroanatomical correlates of critical period plasticity, and his Master of Science from Imperial College London involved investigating functional connectivity in memory and language networks associated with aging.
With an h-index of 41 and over 277 publications, Morales has a substantial record of scholarly output. He is also the founder of Vonova, Inc. His work contributes to fields such as neuroscience, medical imaging, and materials science, with a particular emphasis on neurovascular conditions and advanced medical technologies.
Metrics
- h-index: 41
- Publications: 277
- Citations: 4,975
Selected Publications
-
Middle meningeal artery as a pathway to innovative treatments: ARISE III consensus recommendations (2026)
Collaboration Network
Top Collaborators
- Middle meningeal artery as a pathway to innovative treatments: ARISE III consensus recommendations
- Middle meningeal artery as a pathway to innovative treatments: ARISE III consensus recommendations
- Middle meningeal artery as a pathway to innovative treatments: ARISE III consensus recommendations
- Middle meningeal artery as a pathway to innovative treatments: ARISE III consensus recommendations
- Middle meningeal artery as a pathway to innovative treatments: ARISE III consensus recommendations
- Middle meningeal artery as a pathway to innovative treatments: ARISE III consensus recommendations
- Middle meningeal artery as a pathway to innovative treatments: ARISE III consensus recommendations
- Middle meningeal artery as a pathway to innovative treatments: ARISE III consensus recommendations
- Middle meningeal artery as a pathway to innovative treatments: ARISE III consensus recommendations
- Middle meningeal artery as a pathway to innovative treatments: ARISE III consensus recommendations
- Middle meningeal artery as a pathway to innovative treatments: ARISE III consensus recommendations
- Middle meningeal artery as a pathway to innovative treatments: ARISE III consensus recommendations
- Middle meningeal artery as a pathway to innovative treatments: ARISE III consensus recommendations
- Middle meningeal artery as a pathway to innovative treatments: ARISE III consensus recommendations
- Middle meningeal artery as a pathway to innovative treatments: ARISE III consensus recommendations
Similar Researchers
Based on overlapping research topics